In a bit of blowing their own horn, Heartlab has issued a press release
noting an award from Frost & Sullivan and highlighting their number
three market share position in the cardiology PACS market.

Frost & Sullivan's 2005 survey of the U.S. Cardiology PACS Market
showed Heartlab as the third largest provider of Cardiology PACS
solutions in the U.S. in 2004. With 17.8 percent for direct sales and
2.5 percent for indirect OEM sales (through its parent company, Agfa),
Heartlab has increased its share of the $166 million U.S. market by
more than eight percent from 2002, the last year that Frost &
Sullivan surveyed the market. "As the market continues to evolve,
Heartlab has emerged as the only viable modality independent solution
provider for Cardiology information systems," said Robert Petrocelli,
Heartlab's CEO. "As the market has revealed in other healthcare areas,
there is a trend to consolidate until there are three or four potential
suppliers of a given technology. Heartlab, now the Cardiology Business
Unit for Agfa's HealthCare Business Group, is well positioned to grow
market share beyond 20 percent in the US and expand market share in
other global markets. The cardiology market will continue to evolve
worldwide, and the companies with small market shares will not survive."

Frost applies an interesting (and to me rather arbitrary) segmentation
to cardiology information systems. In radiology, they've divided PACS
from RIS, which makes sense because those two categories of
applications have developed independently with separate sets of
vendors. Cardiology is different, there has never been the equivalent
of an RIS for diagnostic cardiology. Nor are cardiovascular services
simply adding image management to their otherwise automated
departments. The market need is for a cardiovascular information system
(CVIS) that includes both RIS and PACs functionality. So, most all
cardiology "PACS" vendors include RIS-like capabilities because the
customer can't get them anywhere else. Frost's division of the CVIS
market seems more of an artificial one driven by internal structure
than market need.